Navigation Links
MDdatacor Designated as Approved Vendor by CMS for Physician Quality Reporting Initiative
Date:8/27/2008

ATLANTA, Aug. 27 /PRNewswire/ -- MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, announced today that CMS has approved the company as a vendor for the Centers for Medicare & Medicaid Services (CMS).

MDdatacor will automate the collection and submission of clinical information for CMS, relieving the administrative burden of having to hand-write data collection worksheets or manually enter data into a registry system. MDdatacor's patented and interoperable CareInformatix(TM) technology collects clinical data from physician practices' existing electronic medical record, practice management, lab and registry systems, regardless of vendor, as well as from transcribed notes.

Specifically, MDdatacor will submit quality measures data on behalf of providers to CMS as part of the organization's Physician Quality Reporting Initiative (PQRI) for 2008. PQRI is a voluntary pay-for-reporting program designed to improve the quality of patient care provided to Medicare beneficiaries. The program provides payment of up to 1.5% of the total allowed charges for covered Medicare physician fee schedule services to eligible healthcare professionals who successfully report PQRI quality measures.

"MDdatacor has a proven track record of providing physicians with tools that improve patient care while helping them achieve financial rewards for delivering high-quality, evidence-based care," said Tim Roche, co-founder, president and chief executive officer of MDdatacor. "The selection of MDdatacor as an approved CMS vendor demonstrates a viable alternative to using just claims data or manually collecting clinical data for PQRI reporting, even within organizations using disparate IT systems."

About MDdatacor

Established in 2001 and headquartered in Atlanta, Georgia, MDdatacor enhances healthcare quality through the development of innovative technology solutions. MDdatacor solutions are used to support quality improvement, health information exchange and Patient-Centered Medical Home initiatives. MDdatacor currently serves more than 7,000 physicians representing more than seven million patients. For more information, visit http://www.mddatacor.com or call (866) 460-5681.

Contact:

Heather McLarney

(866) 460-5681

Heather.mclarney@mddatacor.com


'/>"/>
SOURCE MDdatacor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
2. China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA
3. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
4. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
5. Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
6. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
7. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
8. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
9. Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
10. Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada
11. CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Investor Conference 2016, to be held February 8-9, ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, taking ... February 10-11, 2016. James Sapirstein , Chief ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
(Date:2/4/2016)... , February 4, 2016 Strasbourg, ... (ABL), Inc. --> Strasbourg, France , ... --> PharmaVentures is pleased to announce that it acted ... biopharmaceutical manufacturing unit in Strasbourg, France , ... --> --> Transgene (Euronext: TNG), ...
Breaking Biology Technology:
(Date:1/7/2016)... Jan. 7, 2016 Various factors have ... products such as biologics and biosimilars. Some of ... healthcare expenditure, growing demand for cost-effective alternatives, growing ... Biosimilars are similar versions of their corresponding patented ... their quality, safety, and efficacy. The global biosimilars ...
(Date:1/6/2016)... Calif. , Jan. 6, 2016  Varam Capital, ... as their trusted partner to deliver advanced authentication solutions ... financial services to the poor. A loan of a ... their lives, giving them the ability to purchase livestock ... to make clothing, or stock for a local store. ...
(Date:1/6/2016)...   A&D Medical , a global leader in ... be unveiling a new line of personal mobile health ... UltraConnect – at CES 2016, with the introduction of its ... monitors. ... upper arm wireless blood pressure monitors represent the launch ...
Breaking Biology News(10 mins):